The Tennessee Valley Healthcare System performed its first CAR-T infusion recently at the Veterans Administration hospital in Nashville.
News: Patient Care
According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.
VUMC is leading an effort to improve cancer care in rural areas with a telehealth initiative supported with a $3.3 million grant from the National Cancer Institute.
Heather Jackson, MSN, RN, APRN, has been promoted to administrative director of Advanced Practice for Vanderbilt-Ingram Cancer Center.
Younger patients say colorectal cancer is a disease that doesn’t follow age guidelines, so pay attention to early symptoms.
Vanderbilt collaborators focused on minimally invasive prostate surgery are developing an endoscopic robotic system with two-handed dexterity at a much smaller scale than existing options.
A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.
Precision oncology expert Dr. Ben Ho Park sheds light on cancer treatment innovations.
The nature of childhood cancer is different than adult cancer, and so is the approach to treatment.
The U.S. Food and Drug Administration (FDA) recently approved ruxolitinib, the first drug for patients with acute graft-versus-host disease (GVHD) who have an inadequate response to steroid treatment.